GREY:ATBPF - Post by User
Comment by
StrikingMooseon Nov 11, 2017 1:32pm
86 Views
Post# 26945441
RE:RE:Clinical Trial
RE:RE:Clinical TrialMy thoughts exactly. I expect SP to go to 40-50 cents on news of good trial results while people wait for any partnerships to happen. Once that happens I expect another good bump in SP dependant on the terms of the deal. Who knows, maybe someone will see potential value in the whole pipeline and try buy the company. One can only speculate what that could be worth. ATB346 was valued in february at $100M which I think is on the low end (judging by the $1M downpayment on 1% market share from tthe licensing deal overseas) so you could assume the other drugs would have likely the same. Add in some premium and a $400-500M buyout for all 3 drugs if the phase 3 goes well for 346 would be seeable.
I'd gladly be buying a round of drinks for everyone here in our Toronto party if that happened haha